Abstract 14: Central Nervous System Deletion of the Bbs1 Gene Causes Obesity and Hypertension in Mice

Hypertension ◽  
2013 ◽  
Vol 62 (suppl_1) ◽  
Author(s):  
Deng-Fu Guo ◽  
Donald A Morgan ◽  
Charles C Searby ◽  
Darryl Y Nishmura ◽  
Val C Sheffield ◽  
...  

Bardet-Biedl syndrome (BBS) is a pleiotropic autosomal recessive disorder with several features including obesity and hypertension. Systemic knock-out mouse models lacking expression of Bbs2, Bbs4 and Bbs6 genes, and Bbs1 M390R knock-in recapitulated many of the BBS phenotypes including obesity. However, the role and contribution of different tissues to the various phenotypes associated with BBS including obesity and hypertension remains unclear. To address this, we generated a new conditional knockout mouse where exon 3 of the Bbs1 gene is floxed. Cre-mediated recombination causes a frame shift resulting in a premature stop. We assessed whether deletion of the Bbs1 gene in the central nervous system (CNS) affects body weight and arterial pressure. Breeding Bbs1 flox with nestin Cre mice created mice deficient in Bbs1 gene only in the CNS as indicated by the loss of Bbs1 gene expression (by RT-PCR) in the hypothalamus, hippocampus, cortex and brainstem, but not in peripheral tissues such as adipose tissue, liver, kidney and skeletal muscle. Importantly, Bbs1 flox /nestin Cre mice display an obesity phenotype as indicated by the increased (P<0.05) body weight (40±1 g vs. 31±1 g in controls) and fat mass measured by MRI (23±2 g vs. 9±1 g in controls) in 25 weeks old mice. We found that the obesity phenotype in Bbs1 flox /nestin Cre mice is due to both an increase (P<0.05) in food intake (4.0±0.2 g vs. 3.1±0.3 g in controls) and reduction in energy expenditure as indicated by the decreased (P<0.05) O 2 consumption (2.8±0.3 mL/100g/min vs. 3.2±0.2 mL/100g/min in controls) and heat production (8.3±0.8 kcal/kg/h vs. 9.4±0.7 kcal/kg/h in controls). These results indicate that hyperphagia and low metabolic rate explain the development of obesity in Bbs1 flox /nestin Cre mice. Finally, we assessed by radiotelemetry the consequence on arterial pressure of ablating the Bbs1 gene throughout the CNS. Interestingly, CNS deletion of the Bbs1 gene recapitulates the hypertension phenotype of BBS as indicated by the elevated mean arterial pressure in Bbs1 flox /nestin Cre (123±3 mmHg) relative to littermate controls (112±4 mmHg, P=0.02). These findings demonstrate that Bbs genes in the CNS are critical for energy homeostasis and arterial pressure regulation.

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Deng F Guo ◽  
Donald A Morgan ◽  
Justin L Grobe ◽  
Darryl Nishimura ◽  
Charles Searby ◽  
...  

Bardet-Biedl syndrome (BBS) is a pleiotropic autosomal recessive disorder associated with several features including obesity and hypertension. Deletion of BBS genes globally or in the nervous system recapitulated many of the BBS phenotypes including obesity and hypertension. Here, we assessed the effect of ablating the Bbs1 gene from the neurons expressing the long signaling form of the leptin receptor (LepRb). Breeding Bbs1 flox with LepRb Cre mice created mice deficient in the Bbs1 gene only in LepRb-positive neurons (visualized by tdTomato expression) as indicated by loss of leptin activation of Stat3. Importantly, Bbs1 flox /LepR Cre mice display an obesity phenotype as indicated by the increased (P<0.05) body weight (39±2 vs. 30±1 g in controls) and fat mass measured by MRI (14±3 vs. 4±1 g in controls) associated with increased (P<0.05) food intake (3.4±0.1 vs. 2.9±0.1 g in controls) in 25 weeks old mice. However, body weight and fat pads of pair-fed LRb Cre /Bbs1 fl/fl mice remained significantly elevated compared to controls suggesting that LRb Cre /Bbs1 fl/fl mice have reduced energy expenditure. Consistent with this possibility, LRb Cre /Bbs1 fl/fl mice displayed decreased (P<0.05) O 2 consumption (2.6±0.1 vs. 3.1±0.1 mL/100g/min in controls) and heat production (8.1±0.3 vs. 9.6±0.3 kcal/kg/h in controls). These results indicate that hyperphagia and decreased energy expenditure contribute to the development of obesity in Bbs1 flox /LepR Cre mice. Next, we assessed the effect on arterial pressure (AP) and sympathetic nerve activity (SNA) of ablating the Bbs1 gene from the LepR-containing neurons. Interestingly, deletion of the Bbs1 gene in LepR neurons recapitulates the hypertension phenotype of BBS as indicated by elevated mean AP (125±4 vs 109±3 mmHg in controls, P=0.03). Conscious renal SNA was also elevated in LRb Cre /Bbs1 fl/fl mice relative to controls (97±8 vs 62±10 spikes/sec, P<0.05). Finally, the depressor effect of ganglionic blockade (hexamethonium) was exaggerated in Bbs1 flox /LepR Cre mice (-57±5 vs -38±5 mmHg in control, P=0.01). These findings demonstrate that the Bbs1 gene in LepR neurons is critical for energy homeostasis and arterial pressure regulation.


Endocrinology ◽  
2013 ◽  
Vol 154 (7) ◽  
pp. 2481-2488 ◽  
Author(s):  
Caroline Fernandes-Santos ◽  
Zhongming Zhang ◽  
Donald A. Morgan ◽  
Deng-Fu Guo ◽  
Andrew F. Russo ◽  
...  

Abstract The pancreatic hormone amylin acts in the central nervous system (CNS) to decrease food intake and body weight. We hypothesized that amylin action in the CNS promotes energy expenditure by increasing the activity of the sympathetic nervous system. In mice, ip administration of amylin significantly increased c-Fos immunoreactivity in hypothalamic and brainstem nuclei. In addition, mice treated with intracerebroventricular (icv) amylin (0.1 and 0.2 nmol) exhibited a dose-related decrease in food intake and body weight, measured 4 and 24 hours after treatment. The icv injection of amylin also increased body temperature in mice. Using direct multifiber sympathetic nerve recording, we found that icv amylin elicited a significant and dose-dependent increase in sympathetic nerve activity (SNA) subserving thermogenic brown adipose tissue (BAT). Of note, icv injection of amylin also evoked a significant and dose-related increase in lumbar and renal SNA. Importantly, icv pretreatment with the amylin receptor antagonist AC187 (20 nmol) abolished the BAT SNA response induced by icv amylin, indicating that the sympathetic effects of amylin are receptor-mediated. Conversely, icv amylin-induced BAT SNA response was enhanced in mice overexpressing the amylin receptor subunit, RAMP1 (receptor-activity modifying protein 1), in the CNS. Our data demonstrate that CNS action of amylin regulates sympathetic nerve outflow to peripheral tissues involved in energy balance and cardiovascular function.


Hypertension ◽  
2015 ◽  
Vol 66 (suppl_1) ◽  
Author(s):  
Balyssa B Bell ◽  
Donald A Morgan ◽  
Mohamed Rouabhi ◽  
Kamal Rahmouni

The adipocyte-derived hormone leptin has a well-established role in the regulation of energy homeostasis, acting in the brain to decrease food intake and promote energy expenditure. Additionally, leptin increases regional sympathetic nerve activity (SNA) and arterial pressure. Multiple intracellular signaling cascades are activated by leptin via its long form receptor (LRb), but the specific roles of these pathways in mediating leptin’s various effects have not been fully understood. Recent evidences suggest that the mechanistic target of rapamycin complex 1 (mTORC1) plays an important role in mediating leptin action. To determine the contribution of mTORC1 to the metabolic and cardiovascular effects of leptin, we generated conditional knockout mice that lack the critical mTORC1 subunit, Raptor, specifically in LRb-expressing cells (LRb Cre /Raptor fl/fl ). Interestingly, body weight was comparable between LRb Cre /Raptor fl/fl mice and controls (29.6±0.8 g vs 31.0±0.8g at 14 weeks of age). Moreover, leptin treatment (1μg/g bw, intraperitoneally, twice daily for 4 days) led to a similar decrease in food intake (-1.6±0.8 g in LRb Cre /Raptor fl/fl mice vs -1.1±1.7 g in controls) and body weight (-5.9±0.8% vs -5.7±0.7%) in both groups. Next, we measured arterial pressure using radiotelemetry at baseline and in response to 2 μg intracerebroventricular (ICV) leptin. Baseline mean arterial pressure (MAP) was comparable between LRb Cre /Raptor fl/fl mice (108±9 mmHg) and controls (103±7 mmHg). However, ICV leptin significantly increased MAP in control mice (30±14 mmHg), but not in LRb Cre /Raptor fl/fl mice (1±9 mmHg, P<0.05 vs controls). The same pattern was observed for systolic and diastolic arterial pressure. Consistent with leptin’s action on MAP, we observed a significant increase in renal SNA in response to ICV leptin in control littermates (106±20%) that was absent in LRb Cre /Raptor fl/fl mice (-28±11%, P<0.05 vs controls) as determined by multifiber sympathetic nerve recordings. Our data suggest a critical role for mTORC1 signaling in mediating the cardiovascular sympathetic but not the metabolic actions of leptin, a dissociation that may have important implications for obesity-associated hypertension.


PLoS Biology ◽  
2013 ◽  
Vol 11 (3) ◽  
pp. e1001506 ◽  
Author(s):  
Viola Nordström ◽  
Monja Willershäuser ◽  
Silke Herzer ◽  
Jan Rozman ◽  
Oliver von Bohlen und Halbach ◽  
...  

2018 ◽  
Vol 16 (S1) ◽  
pp. S55-S64
Author(s):  
G. Hajjaj ◽  
A. Bahlouli ◽  
M. Tajani ◽  
K. Alaoui ◽  
Y. Cherrah ◽  
...  

Ormenis mixta L. is traditionally used for central nervous system (CNS)-related diseases. Its anti-stress properties have received attention in Moroccan traditional medicine and aromatherapy. However, no pharmacological studies have yet been undertaken on this plant in Morocco. The present study provides a preliminary phytochemical screening and psychopharmacological profile of the essential oil and aqueous extract from Ormenis mixta L. by using behavioral tests in vivo, at graded doses. The result of this research shows that Ormenis mixta L. was safe up to 2 g/kg b.w. (body weight) in the acute toxicity study, possesses potential psychostimulant effect, and has antianxiety and antidepressant-like activity. This activity profile of Ormenis mixta L. was similar to the typical psychostimulant, caffeine. The exact mechanism of action underlying this stimulant-like effect should be clarified with further detailed studies. These results explained the extensive use of Ormenis mixta L. as a traditional medicine in Morocco.


2021 ◽  
Vol 22 (4) ◽  
pp. 1587
Author(s):  
Nuri Song ◽  
Da Yeon Jeong ◽  
Thai Hien Tu ◽  
Byong Seo Park ◽  
Hye Rim Yang ◽  
...  

Adiponectin, an adipose tissue-derived hormone, plays integral roles in lipid and glucose metabolism in peripheral tissues, such as the skeletal muscle, adipose tissue, and liver. Moreover, it has also been shown to have an impact on metabolic processes in the central nervous system. Astrocytes comprise the most abundant cell type in the central nervous system and actively participate in metabolic processes between blood vessels and neurons. However, the ability of adiponectin to control nutrient metabolism in astrocytes has not yet been fully elucidated. In this study, we investigated the effects of adiponectin on multiple metabolic processes in hypothalamic astrocytes. Adiponectin enhanced glucose uptake, glycolytic processes and fatty acid oxidation in cultured primary hypothalamic astrocytes. In line with these findings, we also found that adiponectin treatment effectively enhanced synthesis and release of monocarboxylates. Overall, these data suggested that adiponectin triggers catabolic processes in astrocytes, thereby enhancing nutrient availability in the hypothalamus.


2001 ◽  
Vol 82 (10) ◽  
pp. 2319-2326 ◽  
Author(s):  
J. D. Foster ◽  
D. W. Parnham ◽  
N. Hunter ◽  
M. Bruce

This study has examined the distribution of PrPSc in sheep by immunocytochemistry of tissues recovered from terminally affected animals following their experimental infection by the oral route with BSE. Despite a wide range of incubation period lengths, affected sheep showed a similar distribution of high levels of PrPSc throughout the central nervous system. PrPSc was also found in the lymphoid system, including parts of the digestive tract, and some components of the peripheral nervous system. These abundant PrPSc deposits in sheep in regions outside the central nervous system are in direct contrast with cattle infected with BSE, which show barely detectable levels of PrPSc in peripheral tissues. A number of genetically susceptible, challenged animals appear to have survived.


1995 ◽  
Vol 268 (6) ◽  
pp. R1343-R1358 ◽  
Author(s):  
V. L. Brooks ◽  
J. W. Osborn

The importance of the sympathetic nervous system in short-term regulation of arterial pressure is well accepted. However, the question of whether neural systems participate in long-term control of pressure has been debated for decades and remains unresolved. The principal argument against such a control system is that arterial baroreceptors adapt to sustained changes in arterial pressure. In addition, denervation of baroreceptors has minimal to no effect on basal levels of arterial pressure chronically. This argument assumes, however, that baroreceptors provide the primary chronic feedback signal to the central nervous system. An alternate model is proposed in which circulating hormones, primarily arginine vasopressin and angiotensin II, provide a long-term afferent signal to the central nervous system via binding to specific receptors in central sites lacking a blood-brain barrier (circumventricular organs). Studies suggest that the release of the hormones and the sympathetic response to alterations in their plasma concentrations are nonadaptive but may be gated by baroreceptor input. Evidence that this "hormonal-sympathetic reflex" model may explain the long-term alterations in sympathetic activity in response to chronic salt depletion and salt loading as well as congestive heart failure is presented. Finally, the role of an impaired hormonal sympathetic reflex in hypertension, specifically salt-dependent hypertension, is discussed.


2020 ◽  
Vol 40 (10) ◽  
Author(s):  
Cory J. White ◽  
Jieun Lee ◽  
Joseph Choi ◽  
Tiffany Chu ◽  
Susanna Scafidi ◽  
...  

ABSTRACT The metabolic state of the brain can greatly impact neurologic function. Evidence of this includes the therapeutic benefit of a ketogenic diet in neurologic diseases, including epilepsy. However, brain lipid bioenergetics remain largely uncharacterized. The existence, capacity, and relevance of mitochondrial fatty acid β-oxidation (FAO) in the brain are highly controversial, with few genetic tools available to evaluate the question. We have provided evidence for the capacity of brain FAO using a pan-brain-specific conditional knockout (KO) mouse incapable of FAO due to the loss of carnitine palmitoyltransferase 2, the product of an obligate gene for FAO (CPT2B−/−). Loss of central nervous system (CNS) FAO did not result in gross neuroanatomical changes or systemic differences in metabolism. Loss of CPT2 in the brain did not result in robustly impaired behavior. We demonstrate by unbiased and targeted metabolomics that the mammalian brain oxidizes a substantial quantity of long-chain fatty acids in vitro and in vivo. Loss of CNS FAO results in robust accumulation of long-chain acylcarnitines in the brain, suggesting that the mammalian brain mobilizes fatty acids for their oxidation, irrespective of diet or metabolic state. Together, these data demonstrate that the mammalian brain oxidizes fatty acids under normal circumstances with little influence from or on peripheral tissues.


Sign in / Sign up

Export Citation Format

Share Document